Profusa (PFSA) EBT Growth (3y) (2025 - 2026)
Profusa (PFSA) EBT Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 4.82% |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 61.06% |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | -2.57% |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 32.11% |
| 10 | Profusa | 79,003.08 | -295,996.92 | - | -96.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.52% |
| Dec 31, 2025 | -92.15% |
| Sep 30, 2025 | -143.76% |
| Jun 30, 2025 | -104.99% |
| Mar 31, 2025 | -31.94% |